Need a specific person's email?
Browse AM-Pharma's employee directory (about 31 employees) and reveal verified emails free.
AM-Pharma's most common email format is F.Last@am-pharma.com (ex. J.Doe@am-pharma.com), used for 82% of am-pharma.com addresses. AM-Pharma uses 4 email patterns.
| Format | Example | Share of am-pharma.com |
|---|---|---|
| F.Last@am-pharma.comMost common | J.Doe@am-pharma.com | |
| First-Last@am-pharma.com | John-Doe@am-pharma.com | |
| FirMLast@am-pharma.com | JohMDoe@am-pharma.com | |
| Last@am-pharma.com | Doe@am-pharma.com |
Browse AM-Pharma's employee directory (about 31 employees) and reveal verified emails free.
Biotechnology ResearchUtrecht, Netherlands11-50 Employees
AM-Pharma is a Dutch biotechnology company focused on developing therapies for serious medical conditions. Its lead candidate, ilofotase alfa, is being developed as an enzyme replacement therapy for adults with hypophosphatasia. The program focuses on addressing unmet medical needs in severe diseases. It is based in Utrecht, Netherlands, and operates within the biotechnology research sector. In September 2023, AM-Pharma appointed Juliane Bernholz as Chief Executive Officer, marking a notable leadership update.
Most common format
F.Last@am-pharma.com
Example: J.Doe@am-pharma.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.